Illumina upgraded to overweight at JPMorgan on clinical demand outlook

Markets Investing.com By Investing.com 10 Jun 2026 19:13 1 min read

Illumina upgraded to overweight at JPMorgan on clinical demand outlook

Illumina upgraded to overweight at JPMorgan on clinical demand outlook

Illumina upgraded to overweight at JPMorgan on clinical demand outlook

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.